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Abstract
Amyloidoses constitute a group of diseases in which soluble proteins aggregate and deposit extracellularly in tissues.
Nonhereditary apolipoprotein A-I (apoA-I) amyloid is characterized by deposits of nonvariant protein in atherosclerotic
arteries. Despite being common, little is known about the pathogenesis and significance of apoA-I deposition. In this work
we investigated by fluorescence and biochemical approaches the impact of a cellular microenvironment associated with
chronic inflammation on the folding and pro-amyloidogenic processing of apoA-I. Results showed that mildly acidic pH
promotes misfolding, aggregation, and increased binding of apoA-I to extracellular matrix elements, thus favoring protein
deposition as amyloid like-complexes. In addition, activated neutrophils and oxidative/proteolytic cleavage of the protein
give rise to pro amyloidogenic products. We conclude that, even though apoA-I is not inherently amyloidogenic, it may
produce non hereditary amyloidosis as a consequence of the pro-inflammatory microenvironment associated to
atherogenesis.
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Introduction
Apolipoprotein A-I is the major protein constituent of human
high density lipoproteins (HDLs), which play a key role in reverse
cholesterol transport (RCT), shuttling excess of cholesterol (Chol)
from the circulation to the liver for catabolism [1]. Even though
only ,5% of the total circulating apoA-I is found in lipid-free or
lipid-poor forms [2], it is thought that the highly dynamic
catabolism of HDL yields this protein conformation which
subsequently acquires lipids, enhancing Chol removal in both
physiological [3] and proatherogenic conditions [4]. In addition to
its role in lipid homeostasis, apoA-I has been recently shown to
exhibit antioxidant and anti-inflammatory properties [5] and to
inhibit the aggregation and neurotoxicity of the amyloid-b peptide,
the main neurotoxin in Alzheimer’s disease [6]. Although the
possible association between apolipoproteins and neurodegenera-
tion is unclear, increasing apoA-I concentrations have been
reported to correlate with decreasing risk of dementia [7], raising
the possibility of a novel role of apoA-I in physiological
mechanisms of protection against neurological disorders.
About 60% of the secondary structure of apoA-I is organized in
amphipathic a-helices, while the N-terminus is composed of
ß-sheets and unstructured residues [8]. Based on thermodynamic
and circular dichroism measurements, it has been proposed that
lipid-free apoA-I exhibits a molten globule-like state under
physiological conditions [9]. This state guarantees the structural
plasticity of the protein, which partially unfolds when lipids are
released and refolds when lipids are taken up. The structural
disorder required to fulfill protein biological functions represents,
however, a potential risk of self-aggregating unfolded states. Thus
amyloidoses constitute a group of diseases characterized by the
conversion of a natively folded protein into a misfolded
conformation presenting higher content of ß-sheet secondary
structure, which aggregates and deposits causing organ damage
and serious morbidity [10] [11]. Protein aggregation is character-
ized by a remarkable polymorphism, in which oligomers, fibers
and amorphous aggregates are found as final products [12].
Changes in apoA-I structure induced by oxidation [13] and
proteolysis [14] [15] have been described to impair to different
extents its interaction with key proteins involved in RCT and its
ability to remove Chol from artery walls [13]. Conceivably,
changes in apoA-I structure/stability induced by pathological
cellular or extracellular conditions could shift the equilibrium from
a folded structure towards a misfolded conformation prone to
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aggregate in extracellular deposits. Indeed, local deposits of wild
type apoA-I have been detected in the pulmonary vasculature of
elderly dogs [16], in knee joint menisci, inducing amyloidosis
associated with aging [17] and in the aortic intima of elderly
individuals [18].
Although the reason why wild-type apoA-I-derived amyloid is
associated to atherosclerotic plaques [19] is not known, this fact
strongly suggests the importance of the local environment on the
mechanism of protein folding. In the present study, we have
investigated the effects of specific environmental conditions
mimicking a pro-inflammatory milieu on the tendency of apoA-I
to misfold and to self-aggregate into insoluble, amyloid-like
complexes. Results demonstrate the impact of such environmental
agents on the equilibrium between native and aggregation-prone
conformational states of apoA-I, suggesting the importance of
chronic inflammation to induce non-hereditary apoA-I amyloidosis.
Materials and Methods
Materials
Guanidine Hydrochloride (Guanidine Hydrochloride), thio-
flavin T (ThT), Matrix Metalloproteinase-12 (MMP-12, Cata-
lytic Domain) and Hystopaque were from Sigma Chemical Co.
(St Louis, MO). His-purifying resin was from Novagen
(Darmstadt, Germany). Heparin (for clinical application) from
bovine intestinal mucosa (molecular weight ,15 kDa) was from
Rivero (BA, Argentina). 4,49-dianilino-1,19-binaphtyl-5,59-dis-
ulfonic acid, dipotassium salt (bis-ANS) and Alexa Fluor 488
(carboxylic acid, succinimidyl ester, dilithium salt) protein
labeling kit were purchased from Molecular Probes (Invitrogen,
Carlsbad, CA). All other reagents were of the highest analytical
grade available.
Methods
Cloning, expression and purification of wild-type apoA-
I. The cDNA for human apoA-I, kindly donated by Dr A. Jonas
(University of Illinois at Urbana-Champaign, IL), was inserted into
a pET-30 plasmid (Novagen, Madison, WI). Quick Change site
directed mutagenesis kit (Stratagene, La Jolla, CA) was used to
introduce a modification that created an acid labile Asp–Pro
peptide bond between amino acid residues 2 and 3 of apoA-I,
allowing specific chemical cleavage of an N-terminal His-Tag
fusion peptide [20]. Protein expression and purification were
performed as described [20]. Purity of the final protein
preparation (checked by denaturing polyacrylamide gel electro-
phoresis SDS-PAGE) was higher than 95%.
To confirm that the wild-type form behaved as the native
protein, structural and functional tests were performed comparing
the recombinant protein with apoA-I purified from plasma of
healthy donors (not shown). Both, structure and lipid-binding
behaviors were indistinguishable between both proteins, and thus
we will name the wild-type form as ‘‘apoA-I’’ in this manuscript.
Protein denaturation and stability. Chemical denatu-
ration was performed by 2-h incubation of 0.1 mg/mL apoA-I
(at pH 7.4, 5.0 or 4.0, obtained using citrate-phosphate McIlvaines
buffer) at increasing concentrations of GndHCl at 25uC.
Preliminary experiments showed that 2 h were sufficient to
reach equilibrium under these conditions. Measurements were
performed on an Olis upgraded SLM4800 spectrofluorometer
(ISS Inc, Champaign, IL). The free energy of unfolding in the
absence of denaturant (DG0) was obtained from the shift in
spectral center of mass of the fluorescence emission of Trp
residues, assuming a two-state process as previously described
[21,22].
ApoA-I fluorescence quenching by acrylamide. The effect
of pH on secondary structure and exposure of aromatic amino
acids to the solvent was determined by the analysis of intrinsic
fluorescence quenching by acrylamide. ApoA-I emission spectra
were acquired in the presence of increasing concentrations of
acrylamide (0–0.4 M). After correction for buffer effects, the
quenching parameters were calculated using a modified Stern-
Volmer equation as [23]:
F0=DF~1=(fa| K½Q)z 1=fa ð1Þ
where fa is the fraction of the initial fluorescence which is
accessible to the quencher, K is the Stern-Volmer quenching
constant of the accessible fraction and [Q] is the concentration of
the quencher. F0 is the initial fluorescence (contributed by the 4
Trp residues present in apoA-I) and DF is the remaining
fluorescence after the addition of acrylamide at each
concentration. From a linear plot of F0/DF versus 1/[Q] both
K and fa can be obtained.
Binding of bis-ANS. ApoA-I (0.1 mg/mL) was incubated at
different pH values for 24 h at 37uC. Bis-ANS was then added at a
2:1 molar ratio (probe:protein), and fluorescence emission was
measured on a Beckman DTX 880 Microplate Reader, using
excitation and emission filters centered at 395 nm and 490 nm,
respectively.
Fluorescence correlation spectroscopy (FCS). FCS
measures fluctuations in fluorescence produced when a small
number of fluorescent molecules move through an illuminated
volume. The fluctuation can be characterized by the
autocorrelation function, from which the diffusion coefficient
(Dcoef) and the amplitude of the fluctuation G(0) can be readily
obtained [24]. For a single species, G(0) is related to the number of
particles that move through the illuminated volume by G(0) , c/
Nˇ, where Nˇ is the average number of molecules inside the
excitation volume and c is a geometric factor determined by the
shape of the point spread function, the mathematical model used
and the width parameters [25].
FCS was measured on a two-photon fluorescence microscope at
the Laboratory for Fluorescence Dynamics (University of Califor-
nia at Irvine, Irvine, CA), as previously described [26].
Experimental autocorrelation functions were fit using a 3D-
Gaussian intensity profile model [26]. Fluorescein was used to
calibrate the beam waist of the excitation profile function,
considering a Dcoef of 300 mm
2/s [27].
Detection of amyloid-like aggregates. ApoA-I (0.2 mg/
mL) was incubated at different pH values. After 24 h at 37uC,
thioflavin T (ThT) was added at a 1:1 molar ratio and fluorescence
intensities were measured on a Microplate Reader, using
excitation and emission filters centered at 430 nm and 480 nm,
respectively. Plates were then centrifuged at 800 xg at 25uC for
30 min, and fluorescence in the supernatant was measured under
the same conditions. A set of samples treated exactly under the
same conditions was used to quantify total protein remaining in
solution after centrifugation using a Qubit Quantitation Platform
(Invitrogen, Carlsbad, CA). Sedimented protein was expressed as
percentage of the initial amount loaded in each well (20 mg).
Binding to heparin. Binding of apoA-I to heparin was
followed by light scattering. ApoA-I (0.05 mg/mL) was incubated
at different pHs in the absence or presence of heparin (molar ratio
2:1 heparin:protein for 2 h). Light scattering was monitored at 90u
in an Olis upgraded SLM4800 spectrophotofluorometer, with
incident light set at 400 nm [28,29]. In parallel experiments,
formation of amyloid-like complexes was followed by incubation of
apoA-I (0.2 mg/ml) with heparin for 24 h at 37uC followed by
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measurement of ThT fluorescence as described above. Integration
time was set in each experiment separately. The influence of high
salt concentrations on complex formation with heparin was
investigated by carrying out incubations in the presence of
500 mM NaCl.
Pro-inflammatory processing of apoA-I
Processing induced by activated neutrophils. Human
polymorphonuclear neutrophils (PMNs) were isolated from venous
blood of healthy volunteers using a standard method of dextran
sedimentation prior to centrifugation in a Ficoll Hypaque gradient
and hypotonic lysis of erythrocytes. Purified neutrophils contained
.98% viable cells, as determined by trypan blue exclusion. After
isolation, PMNs (16105 cells in 500 mL) were resuspended in
Hanks’ balanced salt solution (HBSS), pH 7.4, containing 1 mM
calcium chloride, 0.5 mM magnesium chloride and 1 mg/mL
glucose. ApoA-I (0.2 mg/mL) was added and, after 5 min at 37uC,
cells were stimulated with 12-O-tetradecanoylphorbol-13-acetate
(TPA) (200 nM), followed by 45 min incubation. Activation was
verified by detecting the conversion of nitroblue tetrazolium to
formazan due to the neutrophils oxidative burst [30]. Reaction
was stopped by spinning the cells at 1,000 x g for 5 min. ApoA-I in
the supernatant was then loaded onto a 16% SDS-PAGE gel and
developed by western blotting using a polyclonal antibody against
apoA-I [31]. An aliquot of apoA-I incubated with PMNs under
identical conditions was used to analyze ThT binding.
Chlorination of apoA-I in a cell-free system. ApoA-I was
dissolved in HBSS, pH 7.4, to obtain a final concentration of
0.2 mg/mL and increasing molar ratios of hypochlorous acid
(HClO) were added while vortexing. To ensure that all the HClO
had reacted, solutions were left for 1 h at room temperature. The
concentration of HClO was determined by measuring the
absorbance at 292 nm (e= 350 M–1 cm–1) at pH 9.0. Reaction
products were analyzed as described above for PMN assays.
Proteolysis with metalloproteinase-12(MMP-12). ApoA-I
was incubated with MMP-12 (at a molar ratio 1:3,000 enzime to
apoA-I) at 37uC for 3 h. An aliquot of the reaction mixture was
analyzed by SDS-PAGE as described above for PMN assays. In
another aliquot, MMP-12 was inhibited by addition of EDTA
(final concentration 5 mM), following 24 h incubation at 37uC to
determine ThT binding as described above.
Chol removal from Chinese Hamster Ovary (CHO)
Cells. To check the influence of the oxidative processing on
protein function, we incubated apoA-I with HClO for 1 h as
described above, and next analyzed the efficiency of the modified
protein to solubilize Chol from CHO cells. Cells were grown until
confluence, and Chol removal determined as described by
Jaureguiberry et al [31]. Efflux was quantified as the percent of
the total Chol removed after 12 h incubation with 12 mg/mL of
HClO-treated apoA-I in comparison with untreated protein.
Other analytical methods. Protein content was quantified
by optical density on a Helios b spectrophotometer (Thermo
Scientific, Waltham, MA), using an extinction coefficient of
1.13 mL/mg at 280 nm. Transmission electron microscopy was
carried out on a JEOL-1200 EX microscope operating at 100 kV.
After different incubation periods, samples were centrifuged at 800
x g and the pellet applied onto Formvar-coated grids for 5 min
and negatively stained with uranyl acetate (2% solution). For long
time incubations of apoA-I, antibiotic-antimycotic mixture
(Invitrogen, Carlsbad, CA) was added to the solution. For
Atomic Force Microscopy (AFM) analysis, protein under the
different treatments was incubated at 0.6 mg/mL for 24 h at
37uC, and spotted stepwise on a freshly cleaved muscovite mica.
Following, the residual sample was blotted off with pure water to
remove salts, and dried under N2. In the case of HClO treatment
and control at pH 7.4, a final concentration of 1 mM CaCl2 was
achieved right before spotting the sample in order to favor protein
adhesion to the substrate. All images were obtained in ambient
conditions using a Multimode-Nanoscope V (Veeco, Santa
Barbara, CA) operating in Tapping Mode with an etched silicon
Probe model Arrow-NCR-50 Nano World (cantilever resonance
frequency: 258 kHz, Force constant 42 N/m; tip radius 5–10 nm).
Typical scan rates were 1 Hz–1.5 Hz.
Unless otherwise stated, experiments are representative of three
independent measurements. Results were means 6 S.E of at least
3 samples. Statistically significant differences between experimen-
tal conditions were evaluated by ANOVA followed by Tukey’s test
(p,0.05).
Results
pH effect on the folding and stability of apoA-I
The effect of pH on the structure and stability of apoA-I was
investigated in equilibrium unfolding experiments by following the
intrinsic fluorescence emission of the protein in the presence of
increasing concentrations of GndHCl. The emission spectrum of
native apoA-I corresponds to the average signal from four
naturally occurring Trp residues (residues number 8, 50, 72 and
108). Shifts in spectral center of mass of the fluorescence emission
indicate the average polarity of the environments surrounding the
Trp residues in a protein. As previously reported [32], equilibrium
at each GndHCl concentration was achieved within a few minutes
and the protein was fully unfolded in the presence of 2.0 M
GndHCl at pH 7.4 (Figure 1). The equilibrium unfolding
transition of apoA-I at pH 7.4 was clearly cooperative and well-
defined by a two-state model. The calculated free energy of
unfolding was 2.3 kcal/mol (Table 1), which suggests that native
apoA-I exhibits a flexible structure likely resembling a molten-
globule state [9]. No changes in the denaturation profile were
observed at pH 5.0 (Fig 1 gray symbols) compared to 7.4 (empty
circles). Instead, at pH 4.0 (Fig. 1 closed symbols) the unfolding
transition appeared to be considerably less cooperative. This
pattern is no longer defined by a two-state model and thus DG0
cannot be estimated. The [GndHCl]1/2 was displaced to higher
concentrations of guanidine and the shifts in Trp exposure to the
aqueous medium extended up to 3 M GndHCl. This behavior
suggests that at pH 4.0 denaturation of apoA-I proceeds via
partially folded intermediate states rather than as a two-state
transition.
The relative exposure of Trp residues to the aqueous solvent is
indicative of protein conformation. To investigate in more detail
the solvent accessibility of Trp residues at different pH values, we
performed quenching of the intrinsic fluorescence emission by
acrylamide. Interaction of Trp residues that are exposed to the
aqueous medium with acrylamide results in nonradiative relaxa-
tion of the excited state, detected as a decrease in fluorescence
intensity [23]. Quenching parameters at the three studied pH
values are summarized in Table 1. The quenching constant (K)
measured at pH 7.4 (5.62 M21) is in good agreement with a
previous report for apoA-I isolated from plasma [33], and with
Davidson et al [34] with the difference that their construct
included an additional Trp residue in a pro-peptide sequence
(position -3). Consistent with results of equilibrium unfolding
experiments described above, a similar quenching constant was
determined at pH 5.0 (5.87 M21), indicating similar exposure of
the Trp residues of apoA-I to the medium. In contrast, at pH 4.0 a
higher quenching constant was determined (7.39 M21), suggesting
increased exposure of Trp residues to the aqueous medium. By
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calculating the fraction of fluorescence accessible to the solvent (fa)
(see ‘‘Methods’’), and considering that apoA-I contains 4 Trp
residues, it was possible to estimate that ,3 Trp residues (fa ,0.7)
were accessible to the quencher in the native state of the protein
(pH 7.4 or 5.0), and that all 4 Trp residues became exposed at pH
4.0 (fa ,1).
To further examine the influence of pH on apoA-I conforma-
tion, we analyzed the binding of the fluorescent probe bis-ANS to
the protein. This probe has been widely used to detect surface
hydrophobicity of proteins [21,22], as its fluorescence quantum
yield increases markedly upon binding to organized hydrophobic
patches at protein surfaces. Figure 2 shows the fluorescence
intensity of bis-ANS added to apoA-I previously incubated (for
24 h at 37uC) at different pH values. Binding (detected as an
increase of fluorescence) was similar at pH 7.4, 6.0 and 5.0. At pH
4.0, however, the fluorescence intensity was,60% lower than that
at the other pH values, indicating loss of binding sites for bis-ANS
on the apoA-I surface.
Fluorescence Correlation Spectroscopy (FCS) was employed to
determine the hydrodynamic properties of apoA-I in a diluted
solution at different pH. Measurements were performed at 37uC at
the two extremes of pH studied (7.4 and 4.0) using apoA-I labeled
with Alexa 488. This probe was chosen because its fluorescence
emission is not dependent on pH. The theoretical diffusion
coefficient (Dcoef) of a molecule can be calculated using the Stokes-
Einstein equation [25]; for apoA-I, with a molecular weight of
28 kDa, this value can be estimated at ,100 mm2/s. From FCS
data, experimentally measured Dcoef values were 11967 and
9869 mm2/s at pH 7.4 and 4.0, respectively (different with
p,0.05). Identical protein concentrations (0.01 mg/mL) were
used and the same average number of molecules in the
illumination volume was recovered from the G(0) value at both
pH values (data not shown). The decrease (by ,18%) in Dcoef at
pH 4.0 compared to the value obtained at pH 7.4 could reflect
either the existence of dimers in solution (a theoretical 20%
decrease in Dcoef would be expected in this case) or the slower
diffusion rate of a monomeric protein in an unfolded configura-
tion. Although it is difficult to discriminate between these two
possibilities using only Dcoef as a parameter, the fact that the same
G(0) value (number of particles in the sampled volume) was
obtained at both pHs is consistent with the interpretation that
apoA-I remained monomeric but in a more disorganized (less
compact) conformation at pH 4.0. This conclusion is also
consistent with the above described results on equilibrium
unfolding, fluorescence quenching and bis-ANS binding at
different pHs values. Interestingly, incubating the samples for
longer periods (,12 h) resulted in the appearance of large
aggregates in the sample at pH 4.0, which were not present at
pH 7.4. In addition, some fluorescence was detected when
focusing the laser at the bottom of the microscope plate, indicating
that acidic pH induced partial sedimentation of the protein during
prolonged incubation times.
Taken together, these results suggest that, at physiological pH,
apoA-I exhibits a flexible conformation that is largely preserved
under mildly acidic conditions (pH 5.0). At pH 4.0 and at low
protein concentrations, apoA-I remains monomeric, but it shows
typical characteristics of partially folded states, including exposure
of Trp residues to the solvent and loss of hydrophobic surface
Figure 1. Equilibrium unfolding of apoA-I at different pHs.
Spectral centers of mass of the intrinsic fluorescence emission of apoA-I
are plotted as a function of [GndHCl]. Final protein concentration was
0.1 mg/mL; excitation was at 295 nm and emission was recorded
between 310 and 420 nm. Experiments were performed at pH 4.0
(black), pH 5.0 (gray), or pH 7.4 (white symbols). Lines are fits to the data
using a sigmoideal model.
doi:10.1371/journal.pone.0022532.g001
Table 1. Stability and solvent exposure of Trp residues of
apoA-I at different pHs.
pH
DGo denat(a) (kcal/
mol) K (M21)(b) fa
(c)
7.4 2.3 +20.3 5.62 +/20.38 0.66 +/20.06
5.0 2.2 +20.4 5.87 +/20.52 0.73 +/20.03
4.0 - 7.39 +/20.39 0.97 +/20.09
aFree energy change of unfolding calculated from equilibrium unfolding curves
is shown in Figure 1 (see ‘‘Methods’’).
bStern-Volmer quenching constant (see ‘‘Methods’’).
cFraction of accessibility of Trp residues to solvent.
doi:10.1371/journal.pone.0022532.t001
Figure 2. pH dependence on bis-ANS binding to apoA-I. ApoA-I
was incubated in optically dark, 96 well microplates, at pH 4.0, 5.0, 6.0
or 7.4 at 37uC for 24 h. Final concentration of apoA-I was 0.1 mg/mL.
Bis-ANS was added at a 2:1 molar ratio to protein, and fluorescence was
measured in a Multiplate Reader (excitation at 395 nm, emission at
490 nm). Bars correspond to means 6 SE. Bars denoted by different
letters differ significantly at p,0.05.
doi:10.1371/journal.pone.0022532.g002
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patches and folding cooperativity. The fact that FCS results
indicated protein aggregation at longer incubation times suggested
that the partially unfolded state of apoA-I induced by acidic pH
exhibited increased propensity to undergo self-association, driving
us to further investigate the nature of aggregates formed.
Thioflavin-T (ThT) binding and ultrastructural analysis of
apoA-I aggregates
Misfolded proteins often give rise to the formation of different
types of protein aggregates, including amyloid fibrils and non-
fibrillar species such as soluble oligomers, which have been
increasingly implicated in a number of important human diseases
[12,35]. To determine whether acidic pH induced amyloid
aggregation of misfolded apoA-I, we measured ThT binding to
the protein following incubation at different pH values. The
fluorescence quantum yield of ThT is very low in aqueous
solution, and it increases significantly upon binding of the probe to
amyloid aggregates [36]. Although ThT binding usually increases
proportionally to the yield of more organized aggregates,
significant fluorescence is detected even when proteins are present
as oligomeric states [37,38]. ApoA-I was incubated at different
pHs for 24 h and ThT fluorescence was measured before and after
low speed centrifugation of the samples (Fig. 3). As expected, ThT
fluorescence was very low (similar to the fluorescence of the same
amount of ThT in the absence of protein, not shown), at both pH
7.4 and 6.0, conditions in which the protein remained native and
soluble after centrifugation. ThT fluorescence increased signifi-
cantly at pH 5.0 and ,15% of the protein in the samples
sedimented upon centrifugation, revealing the presence of
insoluble aggregates. At pH 4.0, ThT binding was also high and
even more protein (30–40%) sedimented after centrifugation,
Figure 3. Binding of ThT to apoA-I. ApoA-I was incubated at pH 4.0,
5.0, 6.0 or 7.4 at a final concentration of 0.2 mg/mL at 37uC for 24 h.
One ml of ThT (1 mM) was added to each well and ThT fluorescence was
measured in a plate reader at 480 nm (excitation at 430 nm) (black
circles). Samples were then centrifuged (800 x g for 10 min) and ThT
fluorescence remaining in the supernatant (empty circles) was
measured. The amount of protein sedimented (gray squares) was
calculated as the percentage of the initial protein (20 mg) remaining in
solution after low-speed centrifugation. Bars correspond to means 6SE.
doi:10.1371/journal.pone.0022532.g003
Figure 4. Morphology of pH-induced apoA-I aggregates. Panels illustrate representative images of apoA-I samples studied by transmission
Electron Microscopy (A–C) and Atomic Force Microscopy (D,E) A) and B) Protein was incubated at 0.4 mg/mL and 37uC for 24 h at pH 7.4 or pH 5.0,
respectively. C) ApoA-I after 48 days incubation at 37uC and pH 5.0. Black arrows in the figures indicate some of the oligomeric structures. D) ApoA-I
(0.6 mg/mL) incubated at pH 5.0 for 24 h at 37uC, and loaded onto mica. Small size oligomers covering the surface of the mica (represented by the
white circle), plus some larger complexes (white arrows) predominated, and some long, thin, unstructured protofibers could also be observed (panel
E). Scale bars are shown in each panel.
doi:10.1371/journal.pone.0022532.g004
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indicating that acidification of the medium promotes aggregation
of apoA-I to form high molecular weight ThT-binding aggregates.
ThT fluorescence in the supernatant was negligible after
centrifugation at all pHs tested.
We next characterized the morphology of apoA-I aggregates by
transmission electron microscopy, after incubating the protein at
0.4 mg/mL and 37uC for 24 h at pH 5.0 and 7.4. As expected, a
homogeneous pattern was observed at pH 7.4 after different
incubation times, indicating the absence of aggregates (Fig. 4A).
Instead, the most conspicuous structures observed at pH 5.0 were
small oligomers ranging from 10 to 50 nm in diameter (Fig 4B),
similar in size and structure to oligomers reported for other
amyloid peptides [39] [40] [41] [12] [42]. Interestingly, these
aggregated species were present at different incubation times and
organized fibers of typical amyloid morphology were not detected
even after 48 days incubation either at pH 5.0 (Fig 4C) or at pH
4.0 (not shown). In order to expand the morphology character-
ization, we performed AFM analysis of the sample in higher
concentrations and overloading the mica with successive applica-
tions of the sample. In this condition, the predominant pattern is
observed as a background composed of closely packed material of
protein oligomers, of an average height ranging between 5 and
10 nm (Fig 4D). In addition, some long, unstructured protofibers
appeared (Fig 4E). Control of protein loaded in the same condition
at pH 7.4, showed small amount of oligomers scattered on a bare
mica (not shown).
Altogether, results indicate that acidic pH alters the delicate
equilibrium between the native and self-associating protein
structure, inducing the formation of insoluble aggregates.
Interestingly, an aggregation-prone conformation of apoA-I is
detected in conditions where only mild structural changes are
observed (pH 5.0).
Aggregation induced by heparin binding
There is abundant evidence that glycosaminoglycans (GAGs)
stimulate the formation of amyloid aggregates from different
proteins [43,44]. Binding of heparin and other GAGs to proteins
has been shown to depend on protein conformation and on pH
[28]. Although it was previously described that apoA-I does not
interact with heparin at neutral pH [45], we tested the possibility
that binding could be modulated by changes in extracellular pH.
Interaction of apoA-I with heparin was analyzed by right-angle
light scattering at low protein concentrations. Light scattering is
proportional to the size of the molecules in solution, and thus it has
been a widely used tool to estimate the formation of high
molecular weight complexes in dilute solution [28]. ApoA-I
(0.05 mg/mL) was incubated at different pH values with or
without heparin (molar ratio 2:1 heparin:protein) for 2 h, and
scattered intensities at 400 nm are shown in Figure 5A. In the
absence of heparin, light scattering was low at all pHs investigated,
indicating that incubation under those conditions had no
significant effect on the aggregation of apoA-I. In contrast, a
different behavior was observed in the presence of heparin. At
both pH 7.4 and 6.0, light scattering was also low, in agreement
with the reported absence of binding sites for heparin on apoA-I at
neutral pH. Acidification of the medium at pH 5.0 and, especially,
at pH 4.0 caused marked increases in light scattering, indicating
that heparin binds to and promotes aggregation of apoA-I at acidic
pH. Interestingly, incubation of apoA-I in the presence of heparin
at pH 5.0 for 24 h resulted in a marked increase of ThT
fluorescence (Fig. 5B), showing an amyloid-like structure of formed
aggregates. Addition of 0.5 M NaCl completely blocked this effect,
suggesting that interaction between apoA-I and heparin at acidic
pH is mediated by salt bridges.
Influence of oxidative and proteolytic modification of
apoA-I on protein folding and function
The effect of a pro-inflammatory environment on the
structure and function of apoA-I was mimicked by incubating
the protein with TPA-stimulated neutrophils, as the activation
of these cells is known to lead to complex pathways including
oxidative and proteolytic reactions. First, we set up to establish
the consequence of such events on protein structure and
misfolding. Incubation of apoA-I with activated PMN resulted
in partial protein degradation, determined by a decrease of
intensity in the 28 kDa band corresponding to the intact protein
and appearance of a fragment of ,22 kDa in SDS-PAGE
(Fig. 6A). In some experiments, degradation was considerably
more drastic, with complete disappearance of the intact apoA-I
band and appearance of high-molecular weight cross-linked
products (not shown). Interestingly, partially degraded apoA-I
bound significantly more ThT than the intact protein (Fig. 6B),
Figure 5. Binding to heparin as a function of pH and salt
concentration. (A) Light scattering signal (at 400 nm) of 0.05 mg/mL
apoA-I incubated for 2 h at different pH values in the absence (black
bars) or in the presence (white bars) of heparin (2:1 molar ratio
heparin:protein). (B) ThT binding to heparin-apoA-I complex at pH 5.0 in
the presence or absence of 500 mM ClNa. ThT fluorescence was
measured as described in Figure 3. Bars correspond to means 6SE. Bars
denoted by different letters differ significantly at p,0.05.
doi:10.1371/journal.pone.0022532.g005
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suggesting that PMN-mediated processing of apoA-I gives rise
to a pro-amyloidogenic conformation.
Proteolytic degradation has been previously observed upon
incubation of apoA-I with macrophages, yielding protein frag-
ments with sizes 26, 22, 14 and 9 kDa, which corresponded to
both, the N and C terminus of the protein [14]. As metallopro-
teinases are known to be highly activated in leukocytes, we
checked the effect that metalloproteinase 12 (MMP-12, present in
atherosclerotic lesions [46]), could exert on apoA-I pro amiloido-
genic processing. Figure 6C shows, as expected, that apoA-I is in
some extent substrate of this enzyme, detected as a slight decrease
in the intensity of the band associated to original molecular size,
together with the appearance of fragments of lower molecular
weight; nevertheless, the product does not seem to be amiloido-
genic, as the binding to ThT does not change significantly (Fig 6D).
In addition to proteolysis, different oxidative species are
involved in the respiratory burst of activated neutrophils [47].
One of the characteristic responses is the formation of the powerful
oxidant and microbicidal agent, HClO, in a reaction catalyzed by
myeloperoxidase [48]. To test this effect in vitro, apoA-I was
incubated at increasing concentrations of HClO and protein
integrity was analyzed by SDS-PAGE. Incubation of apoA-I with
HClO has been previously tested, and fragmentation of the
protein appeared to occur in a random process, as distinct low
molecular mass complexes were not detected in that case [49].
Also, in agreement with that report, apoA-I degradation occurred
as a function of increasing concentrations of HClO (Fig. 7A, lower
panel). To analyze the pro-amyloidogenic processing, we tested
ThT fluorescence associated to these products. Interestingly, ThT
binding did not linearly correlate with HClO-induced degradation
Figure 6. Effect of TPA-activated neutrophils and MMP-12 on apoA-I processing and amyloidogenicity. ApoA-I (0.2 mg/mL) was
incubated in the presence of TPA-stimulated neutrophils at pH 7.4 at 37uC for 1 h. (A) Western blotting of aliquots of the supernatant developed with
rabbit polyclonal anti-apoA-I. Lanes 1 to 3 show samples incubated in the absence of neutrophils, while lanes 4 to 6 represent the same amount of
protein applied to each lane after neutrophil treatment. (B) ThT binding to apoA-I previously incubated (24 h at 37uC) in the absence (labeled as
ApoA-I) or in the presence of TPA-stimulated neutrophils (ApoA-I + PMN). As an additional control, ThT fluorescence associated to neutrophils
incubated under the same conditions without apoA-I is also shown (bar labeled PMN). In a different experiment apoA-I (0.2 mg/mL) was incubated in
the presence of MMP-12. (C) Western blotting was developed as in (A). Numbers on the left side of the figures (A) and (C) correspond to Molecular
Weight Markers (GE Healthcare, Uppsala, Sweden). (D) After 3 h at 37uC, MMP-12 was inhibited and apoA-I incubated as in (B) to determine ThT
binding. Bars correspond to means 6SE. Bars denoted by different letters differ significantly at p,0.05.
doi:10.1371/journal.pone.0022532.g006
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of apoA-I. Instead, ThT fluorescence was maximal at an
intermediate HClO:protein molar ratio, but it decreased at higher
oxidant concentrations (Fig. 7A, upper panel). Again we
characterized these products by microscopy techniques. Samples
incubated at 100 mM HClO at low concentrations were observed
by electron microscopy as amorphous aggregates (Fig 8A). When
incubated at higher concentrations (0.6 mg/mL) and overloaded
on the mica, AFM images showed that, in addition to the
predominant aggregates, long and short, thin protofibers could be
detected in small yield (Fig 8B and C) suggesting that, under more
drastic conditions the oligomers could give rise to more organized
structures.
These evidences suggest that partial oxidative modification of
apoA-I gives rise to amyloidogenic products, whereas further
modification by HClO likely results in a more severely unfolded
protein conformation that is no longer amyloidogenic. Formation
of cross-linked products was also sometimes observed at higher
HClO concentrations (Fig. 7B).
Next, we attempted to characterize the influence of partial
oxidation events on the ability of apoA-I to remove Chol from
CHO cells. Results showed a significant decrease in protein ability
to solubilize Chol (Fig 9), indicating that partial structural
modification impairs its ability to participate in cellular Chol
homeostasis.
Discussion
Mutant forms of apoA-I have been involved in late-onset
familial amyloidosis [50]. Such mutations are rare and usually
associated with systemic deposition of amyloid in tissues, the major
clinical features being related to renal, hepatic, and cardiac
dysfunction. The possibility that wild-type apoA-I could also be
Figure 7. Effect of HClO on apoA-I processing and amyloidogenicity. ApoA-I (0.2 mg/mL) was incubated at increasing concentrations of
HClO (as indicated) for 60 min at room temperature. (A) An aliquot (20 ml) of each sample was resolved on SDS-PAGE and silver stained. Control, non-
modifed apoA-I is shown in the first lane (lower panel). Another aliquot was further incubated at 37uC for 24 h and ThT binding was measured (upper
panel). Bars correspond to means 6 SE. Bars denoted by different letters differ significantly at p,0.05. (B) Western blotting (against apoA-I as
indicated in Fig. 5) of HClO-treated apoA-I samples. Lanes 1 to 3 correspond to apoA-I incubated with 0, 25 and 200 mM HClO, respectively.
doi:10.1371/journal.pone.0022532.g007
Figure 8. Morphology of HClO-induced apoA-I aggregates. Panels illustrate representative images of apoA-I samples studied by transmission
Electron Microscopy (A) and Atomic Force Microscopy (B,C) A) Protein was incubated at 0.2 mg/mL for 24 h and 37uC at 100 mM HClO. Black arrow
shows representative aggregates. B and C) ApoA-I (0.6 mg/mL) for 24 h and 37uC at 100 mM HClO, and loaded stepwise onto the mica. Small size
oligomers covering the surface of the mica (represented by the white circle), plus some short (B) and long (C) thin protofibers (white arrows) could be
observed. Scale bars are shown in each panel.
doi:10.1371/journal.pone.0022532.g008
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amyloidogenic has been previously raised, as it was localized in
senile plaques or associated to atherosclorosis lesions [18,19].
However, very little is known about the events that might trigger
amyloid aggregation of wild-type or mutant forms of apoA-I.
Following its synthesis, apoA-I circulates in plasma and lymph
associated to human HDLs and is normally eliminated by filtration
in kidney after 4–6 days. Nevertheless, the fact that diffuse deposits
of wild type apoA-I are often found associated to age-related and
atherosclerotic lesions indicates that, under specific conditions, the
protein could lose its structure and aggregate. Thus, both
reversible agents (local pH, molecular crowding, interaction with
ligands or other biomolecules, etc) and permanent chemical
modifications should be taken into account to investigate those
factors responsible for aggregation of apoA-I and their possible
relationship with amyloidosis.
Atherosclerosis represents a pathological process that underlies
the formation of plaques in the intima and media of the arterial
wall, resulting from the progressive accumulation of Chol, other
oxidized lipids and inflammatory cells. This landscape has been
shown to impair HDL and apoA-I function [51]. As activation of
inflammatory cells results in a decrease of pH [52], proteolysis and
oxidation of specific and unspecific substrates, we have analyzed
here the influence of some of these events as possible mediators of
apoA-I misfolding.
Effect of local pH on protein structure and solubility
A critical condition to be considered is the extracelullar pH in
the interstitial compartment. Normal oxidative catabolism yields
protons which are mostly neutralized by different physiological
buffers. However, a local decrease in extracellular pH can occur
not only under inflammation [52] but also in chronic hypoxic
conditions, which, in addition, induce lactic acidosis.
To investigate the influence of acidification of the medium on
apoA-I folding, we exposed the protein to buffers at different pHs.
Incubation at pH 6.0 had no effect on the stability and solubility of
apoA-I compared to pH 7.4, and no significant binding to ThT
was detected, indicating preservation of the native fold. This is not
surprising as the iso electric point of apoA-I is 5.27 and thus, the
net charge of the protein was largely preserved at pH 6.0. In
contrast, at pH 4.0 the structure and stability of apoA-I were
significantly modified. Equilibrium unfolding by GndHCl revealed
loss of cooperativity in the unfolding transition. Changes in protein
conformation were further evidenced by fluorescence quenching,
FCS, bis-ANS binding and ThT fluorescence measurements.
Although relevant, results at pH 4.0 are far from in vivo
landscapes, and thus especial attention should be paid to
incubations performed at higher pH. Interestingly, the detection
of some increase in ThT fluorescence, along with a decrease in
protein solubility and the presence of small aggregates in these
samples indicate that the amyloidogenicity of the protein becomes
evident at pH 5.0, in spite of the fact that apoA-I retained a mostly
native structure at this pH. Similar behavior has been detected for
other amyloidogenic proteins, such as transthyretin [53]. From
over 70 pro-amyloidogenic natural mutations described for
transthyretin, several of them did not show drastic structural
changes, except for weaker bonding at protein contacts which
increased protein insolubility.
It is also conceivable that at low pH new interactions could be
created between apoA-I and other biomolecules in the cellular
matrix. As glycosaminoglycans have been shown to stimulate
formation of fibrils from different amyloidogenic proteins [43], we
analyzed the interaction of apoA-I with heparin at different pHs.
Results showed that a mild decrease in pH not only generated
binding sites for heparin in apoA-I, but it gave rise to formation of
complexes with amyloid characteristics (i.e., ThT binding),
stabilized by electrostatic interactions.
Heparin binding sites in proteins are usually characterized by
a cluster of basic residues capable of interacting with the
negatively charged heparin polymer. Many different motifs have
been postulated as heparin binding domains in proteins [54].
Hileman et al. [55] have proposed a consensus sequence in
which turns from the protein folding bring basic interacting
amino acid residues into proximity. The pKa of free histidine is
about 6, but it is well-known that ionizable side chains can
exhibit changes in their apparent pKa, depending on the
physicochemical properties of the surrounding protein environ-
ment. Thus, it is possible that some histidine residues in apoA-I
could become protonated at pH close to 5. ApoA-I has 5
Figure 9. Cholesterol efflux mediated by HClO-processed
apoA-I: Chinesse Hamster Ovary Cells were labeled with 3H Chol and
incubated with apoA-I as indicated in Methods. Results are shown as
the % of radioactivity removed by apoA-I, either being treated (ApoA-I
+ HClO) or not (ApoA-I) with ,50 mM HClO. Column labeled as Control
refers to cells incubated under the same conditions but in the absence
of the protein. Bars correspond to means 6SE.
doi:10.1371/journal.pone.0022532.g009
Figure 10. Helical wheel model of putative A a-helix comprised
between amino acid residues 147 and 163 of apoA-I. Helix is
seen down the long axis, and representing an amino acid arrangement
considering an ideal a-helix (l00u rotation per residue). Gray scale in the
figure corresponds to the nature of different amino acids.
doi:10.1371/journal.pone.0022532.g010
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histidine residues (positions 135, 155, 162, 193, 199). Two of
them (residues 155 and 162) are located in a putative
amphipatic class A a-helix, separated by a periodicity that
allows a turn of the helix to bring them in close proximity, and
near an arginine residue that is seven amino acids apart in the
same helix. By considering the helix-wheel model (Fig. 10), this
spatial sequence of 3 amino acids is located in the polar face
adjacent to the non polar face in the helix 6. Thus, protonation
of the His residues would increase the concentration of positive
charges on the polar side of the helix, favoring interaction with
negatively charged membranes (like in apoptotic cells) or
components of the extracellular matrix.
Effect of chemical modifications on apoA-I
Our findings strongly suggest that chemical modification of
apoA-I induced by conditions mimicking a pro-inflammatory
environment results in the processing of apoA-I into partially
degraded, amyloidogenic products. As metalloproteinases are
highly activated in atherosclerotic plaques [2], we checked
whether the incubation of apoA-I with MMP-12 could result in
the formation of a peptide with amyloidogenic properties. As
expected apoA-I degradation was observed, but this event did
not seem to be responsible as the product is not amyloidogenic.
Nevertheless, it could be possible that other peptide could be
freed under proteolytic processing, as apoA-I hereditary
amyloidosis is usually characterized by the presence of N-
terminal fragments of the protein in the lesions. By purifying
one of these fragments, Andreola et al [56] demonstrated that
the acidification of the medium induced the shift from
unordered to b sheet conformation and the formation of fibrils
from the isolated peptide.
Instead, oxidation is likely to be critical in the pathological
processing of the protein, as myeloperoxidase, an enzyme present
in polymorphonuclear cells, and its products, as HClO, have
been directly involved at different stages of atherosclerotic lesions
[57]. When incubating apoA-I with HClO, we showed that the
protein was extensively degraded (Fig 5). Degradation included
proteolysis and probably oxidation mediated by HClO, as
methionine [13], tyrosine [58] and tryptophan [59] residues
have been shown to react with myeloperoxidase-generated
HClO. Interestingly, partially degraded apoA-I showed a
significant ThT-associated fluorescence, indicating a product
more prone to aggregate into an amyloid form than the native
protein (Fig 6). This observation is really important, as it shows a
clear demonstration of the relationship between atherosclerosis
and apoA-I-induced amyloidosis. In addition, the oxidized
protein loses its ability to remove Chol. This fact could result
in the accumulation of Chol in peripheral cells, which is in fact a
signal to induce apoptosis, leading to exposure of phosphatidyl-
serine in the outer leaflet of the plasma membrane. Presence of
negatively charged lipids in the plasma membrane can induce
further local acidification of the pH [60] in the interstitial fluid,
which in turn could elicit the conformational shift of apoA-I into
a pathological misfolding.
A lower pH induced by pro-inflammatory conditions could also
increase binding of apoA-I to the extracellular matrix, extending
the time during which apoA-I and HDLs are exposed to
macrophage-mediated oxidative damage.
In conclusion, our results strongly suggest that different events
taking place in the inflammatory hallmark of atherosclerosis
conduct to a pro-amyloidogenic processing of apoA-I which in
turn could impair the vascular disease. Although most of the
apoA-I circulates associated to HDL, the protein in the lipid-
bound state is more stable and protected from the chemical
processing, and thus the lipid-poor or lipid-free conformation is
the candidate to induce amyloidogenic products. The fact that
macrophages increase the yield of this conformation locally at
the artery wall [4] supports this concept. Furthermore, the
concentration of lipid-free apoA-I in the aortic intima has
been shown to increase during the progression of atheroscle-
rosis [61].
Finally, although not tested here, the amyloidogenic conforma-
tions of apoA-I are likely to perpetuate the vascular disease as the
protein pathological conformation could be cytotoxic and elicit the
inflammatory environment. Further research will be done on this
topic.
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